DNA2 inhibitor C5

CAS No. 35973-25-2

DNA2 inhibitor C5 ( —— )

Catalog No. M24317 CAS No. 35973-25-2

DNA2 inhibitor C5 is a promising lead compound to develop sensitizers for cancer chemotherapeutics that cause replication stress and it also is a competitive and specific inhibitor of DNA2 nuclease activity (IC50: 20 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 69 In Stock
5MG 110 In Stock
10MG 178 In Stock
25MG 410 In Stock
50MG 605 In Stock
100MG 860 In Stock
500MG 1728 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DNA2 inhibitor C5
  • Note
    Research use only, not for human use.
  • Brief Description
    DNA2 inhibitor C5 is a promising lead compound to develop sensitizers for cancer chemotherapeutics that cause replication stress and it also is a competitive and specific inhibitor of DNA2 nuclease activity (IC50: 20 μM).
  • Description
    DNA2 inhibitor C5 is a promising lead compound to develop sensitizers for cancer chemotherapeutics that cause replication stress and it also is a competitive and specific inhibitor of DNA2 nuclease activity (IC50: 20 μM). DNA2 inhibitor C5 inhibits nuclease, DNA dependent ATPase, helicase, and DNA binding activities of DNA2.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    DNA2 nuclease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    35973-25-2
  • Formula Weight
    234.2
  • Molecular Formula
    C10H6N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:31.25 mg/mL (133.45 mM; Need ultrasonic)
  • SMILES
    O=C(C1=C(O)C2=CC=CC([N+]([O-])=O)=C2N=C1)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Binghui Shen, et al. Dna2 inhibitors for cancer treatment. US20170226063A1.
molnova catalog
related products
  • Ac-DEVD-pNA

    Ac-DEVD-pNA is the preferred peptidic substrate for caspase-3.

  • Decane

    Reference standards.

  • Neomangiferin

    Neomangiferin has beneficial effects on high fat diet-induced nonalcoholic fatty liver disease in rats.